Glorious Finance Ltd - Net Worth and Insider Trading

Glorious Finance Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glorious Finance Ltd owns 1 companies in total, including CytoMed Therapeutics Ltd (GDTC) .

Click here to see the complete history of Glorious Finance Ltd’s form 4 insider trades.

Insider Ownership Summary of Glorious Finance Ltd

Ticker Comapny Transaction Date Type of Owner
GDTC CytoMed Therapeutics Ltd 2023-03-31 10 percent owner

Glorious Finance Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Glorious Finance Ltd Ownership Network

Ownership Network List of Glorious Finance Ltd

No Data

Ownership Network Relation of Glorious Finance Ltd

Insider Network Chart

Glorious Finance Ltd Owned Company Details

What does CytoMed Therapeutics Ltd do?

Who are the key executives at CytoMed Therapeutics Ltd?

Glorious Finance Ltd is the 10 percent owner of CytoMed Therapeutics Ltd. Other key executives at CytoMed Therapeutics Ltd include director & 10 percent owner Chee Kong Choo , director & CSO and CMO Jieming Zeng , and 10 percent owner Shu Wang .

CytoMed Therapeutics Ltd (GDTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoMed Therapeutics Ltd (GDTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoMed Therapeutics Ltd (GDTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoMed Therapeutics Ltd (GDTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytoMed Therapeutics Ltd Insider Transactions

No Available Data

Glorious Finance Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Glorious Finance Ltd. You might contact Glorious Finance Ltd via mailing address: 18 Namly Grove South, Singapore U0 267310.

Discussions on Glorious Finance Ltd

No discussions yet.